116 related articles for article (PubMed ID: 19562337)
1. Focal fat mimicking multiple hepatic metastases on FDG PET/CT imaging.
Zissen MH; Quon A
Eur J Nucl Med Mol Imaging; 2009 Sep; 36(9):1527. PubMed ID: 19562337
[No Abstract] [Full Text] [Related]
2. Prone 18F-FDG PET/CT changes diagnostic and surgical intervention in a breast cancer patient: some considerations about PET/CT imaging acquisition protocol.
Canevari C; Gallivanone F; Zuber V; Marassi A; Losio C; Gianolli L; Gilardi MC; Castiglioni I
Clin Imaging; 2015; 39(3):506-9. PubMed ID: 25620014
[TBL] [Abstract][Full Text] [Related]
3. Prediction of Advanced Axillary Lymph Node Metastases (ypN2-3) Using Breast MR imaging and PET/CT after Neoadjuvant Chemotherapy in Invasive Ductal Carcinoma Patients.
Kim WH; Lee SW; Kim HJ; Chae YS; Jeong SY; Jung JH; Park HY; Lee WK
Sci Rep; 2018 Feb; 8(1):3181. PubMed ID: 29453385
[TBL] [Abstract][Full Text] [Related]
4. Multiple liver focal fat sparing lesions with unexpectedly increased (18)F-FDG uptake mimicking metastases examined by ultrasound (18)F-FDG PET/CT and MRI.
Han N; Feng H; Arnous MM; Bouhari A; Lan X
Hell J Nucl Med; 2016; 19(2):173-5. PubMed ID: 27331215
[TBL] [Abstract][Full Text] [Related]
5. The role of (18)F-FDG PET/CT in initial staging of patients with locally advanced breast carcinoma with an emphasis on M staging.
Mittal BR; Manohar K; Kashyap R; Bhattacharya A; Singh B; Singh G
Hell J Nucl Med; 2011; 14(2):135-9. PubMed ID: 21761015
[TBL] [Abstract][Full Text] [Related]
6. [Not Available].
Hamerla G; Meyer HJ; Purz S; Surov A
Rofo; 2018 Oct; 190(10):971-972. PubMed ID: 29665589
[No Abstract] [Full Text] [Related]
7. Inflammatory pseudotumours resembling multiple hepatic metastases and their complete regression, as revealed by 18F-FDG PET/CT.
Chong A; Jeong SY; Min JJ
Eur J Nucl Med Mol Imaging; 2009 Jul; 36(7):1199-200. PubMed ID: 19415271
[No Abstract] [Full Text] [Related]
8. 18F-FDG PET/CT Findings in Portal Vein Thrombosis and Liver Metastases.
Surasi DS; O'Malley JP; Bhambhvani P
J Nucl Med Technol; 2015 Sep; 43(3):229-30. PubMed ID: 25655342
[TBL] [Abstract][Full Text] [Related]
9. Metastatic cancer in thyroid detected by FDG PET.
Hsu CH; Wu CH; Chu JS
Clin Nucl Med; 2006 Jan; 31(1):51-2. PubMed ID: 16374131
[No Abstract] [Full Text] [Related]
10. Solitary breast metastasis from recurrent gallbladder carcinoma simulating a second primary on 18F-FDG PET/CT.
Khangembam BC; Sharma P; Naswa N; Sahoo MK; Kumar R
Clin Nucl Med; 2013 Nov; 38(11):e433-4. PubMed ID: 24096996
[TBL] [Abstract][Full Text] [Related]
11. Solitary hepatic metastasis from medullary thyroid carcinoma mimicking atypical hemangioma: insights from multimodality diagnostic approach by MRI, F-18 FDG and F-18 FDOPA PET/CT.
Imperiale A; Greget M; Chabrier G; Keomany J; Rust E; Detour J; Pessaux P; Goichot B
Clin Nucl Med; 2010 Jun; 35(6):434-7. PubMed ID: 20479594
[No Abstract] [Full Text] [Related]
12. Positron emission tomography: is it a better way to detect metastases?
Gupta S; Badwe RA
Natl Med J India; 2004; 17(6):323-5. PubMed ID: 15736555
[No Abstract] [Full Text] [Related]
13. Intense FDG activity in focal hepatic steatosis.
Le Y; Chen Y; Huang Z; Cai L; Zhang L
Clin Nucl Med; 2014 Jul; 39(7):669-72. PubMed ID: 24873789
[TBL] [Abstract][Full Text] [Related]
14. 18F-2-fluoro-2-deoxy-d-glucose positron emission tomography in staging of locally advanced breast cancer.
van der Hoeven JJ; Krak NC; Hoekstra OS; Comans EF; Boom RP; van Geldere D; Meijer S; van der Wall E; Buter J; Pinedo HM; Teule GJ; Lammertsma AA
J Clin Oncol; 2004 Apr; 22(7):1253-9. PubMed ID: 15051773
[TBL] [Abstract][Full Text] [Related]
15. Role of [18F]FDG-PET/CT after radiofrequency ablation of liver metastases: preliminary results.
Travaini LL; Trifirò G; Ravasi L; Monfardini L; Della Vigna P; Bonomo G; Chiappa A; Mallia A; Ferrari M; Orsi F; Paganelli G
Eur J Nucl Med Mol Imaging; 2008 Jul; 35(7):1316-22. PubMed ID: 18338164
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic performance of fluorodeoxyglucose-positron emission tomography/computed tomography combined with ultrasonography-guided fine needle aspiration cytology for identifying axillary lymph node status in patients with breast cancer.
Machida Y; Kubota K; Katayama T; Toriihara A; Shibuya H
Eur J Surg Oncol; 2013 Jan; 39(1):26-30. PubMed ID: 23122913
[TBL] [Abstract][Full Text] [Related]
17. Response to low-dose oral capecitabine monotherapy in an elderly frail patient with metastatic breast carcinoma and impaired renal function: documentation by fluorodeoxyglucose positron emission tomography.
Basu S; Baghel NS
Jpn J Radiol; 2011 May; 29(4):291-2. PubMed ID: 21607846
[No Abstract] [Full Text] [Related]
18. Impact of Pretreatment Combined (18)F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Staging on Radiation Therapy Treatment Decisions in Locally Advanced Breast Cancer.
Ng SP; David S; Alamgeer M; Ganju V
Int J Radiat Oncol Biol Phys; 2015 Sep; 93(1):111-7. PubMed ID: 26279029
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological and prognostic relevance of uptake level using 18F-fluorodeoxyglucose positron emission tomography/computed tomography fusion imaging (18F-FDG PET/CT) in primary breast cancer.
Ueda S; Tsuda H; Asakawa H; Shigekawa T; Fukatsu K; Kondo N; Yamamoto M; Hama Y; Tamura K; Ishida J; Abe Y; Mochizuki H
Jpn J Clin Oncol; 2008 Apr; 38(4):250-8. PubMed ID: 18407934
[TBL] [Abstract][Full Text] [Related]
20. Metastatic breast cancer mimicking benign fatty liver infiltration.
Martinez SR; Hagge RJ; Christensen SD; Webb JM
Breast J; 2008; 14(1):108. PubMed ID: 18186875
[No Abstract] [Full Text] [Related]
[Next] [New Search]
